Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul 18;283(29):19922-6.
doi: 10.1074/jbc.M802639200. Epub 2008 May 23.

Protein Z-dependent protease inhibitor binds to the C-terminal domain of protein Z

Affiliations

Protein Z-dependent protease inhibitor binds to the C-terminal domain of protein Z

Alireza R Rezaie et al. J Biol Chem. .

Abstract

Protein Z (PZ) is a multidomain vitamin K-dependent plasma protein that functions as a cofactor to promote the inactivation of factor Xa (fXa) by PZ-dependent protease inhibitor (ZPI) by three orders of magnitude. To understand the mechanism by which PZ improves the reactivity of fXa with ZPI, we expressed wild-type PZ, PZ lacking the gamma-carboxyglutamic acid domain (GD-PZ), and a chimeric PZ mutant in which both Gla and EGF-like domains of the molecule were substituted with identical domains of fXa. The ZPI binding and the cofactor function of the PZ derivatives were characterized in both binding and kinetic assays. The binding assay indicated that all PZ derivatives interact with ZPI with a similar dissociation constant (K(D)) of approximately 7 nm. However, the apparent K(D) for the chimeric PZ-mediated ZPI inhibition of fXa was elevated 6-fold on PC/PS vesicles and its capacity to function as a cofactor to accelerate the ZPI inhibition of fXa was also decreased 6-fold. The cofactor activity of GD-PZ was dramatically impaired; however, the deletion mutant exhibited a normal cofactor function in solution. A chimeric activated protein C mutant containing the Gla domain of fXa was susceptible to inhibition by ZPI in the presence of PZ. These results suggest that: (i) the ZPI interactive site of PZ is located within the C-terminal domain of the cofactor and (ii) a specific interaction between the Gla domains of PZ and fXa contributes approximately 6-fold to the acceleration of the ZPI inhibition of fXa on phospholipid membranes.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
SDS-PAGE analysis of PZ derivatives under non-reducing conditions. Lane 1, plasma-derived PZ (pPZ); lane 2, recombinant PZ (rPZ); lane 3, PZ-fX/LC; lane 4, GD-PZ; lane 6, molecular mass standards in kDa.
FIGURE 2.
FIGURE 2.
Dependence of kobs values on the concentration of PZ derivatives in ZPI inhibition of fXa and the competitive effect of GD-PZ on fXa inhibition by the PZ-ZPI complex. A, the kobs values for the ZPI (5 nm) inhibition of fXa (0.5 nm) in the presence of increasing concentrations of pPZ (○), rPZ (•), and PZ-fX/LC chimera (□) were determined on PC/PS vesicles (20 μm) in TBS/Ca2+ at room temperature by an amidolytic activity assay described under “Experimental Procedures.” The non-linear regression analysis of data yielded Kd(app) values of 1.1 ± 0.1 nm for pPZ, 1.5 ± 0.2 nm for rPZ, and 8.7 ± 0.9 nm for PZ-fX/LC. B, the competitive effect of GD-PZ on inhibition of fXa (0.5 nm) was monitored in the presence of ZPI (5 nm) and pPZ (10 nm) on PC/PS vesicles (20 μm) in TBS/Ca2+ at room temperature by an amidolytic activity assay. The non-linear regression analysis of data yielded Kd(app) values of 29 ± 5 nm for the GD-PZ inhibition of the PZ cofactor activity. Data are derived from averages of 2–3 independent measurements from single batches of protein preparations.
FIGURE 3.
FIGURE 3.
The binding of PZ derivatives to ZPI. An ELISA-based binding assay using a polyclonal anti-ZPI (2 μg/ml) as the capture antibody was used to evaluate the affinity of PZ derivatives for interaction with the serpin as described under “Experimental Procedures.” The symbols are: pPZ (○), rPZ (•), PZ-fX/LC chimera (□), and GD-PZ (▪). The non-linear regression analysis of data according to a hyperbolic equation yielded KD values of 7.5 ± 0.5 nm for pPZ, 7.1 ± 0.1 nm for rPZ, 8.4 ± 0.1 nm for PZ-fX/LC, and 7.1 ± 0.2 nm for GD-PZ. Data are derived from averages of at least 2–3 independent measurements.
FIGURE 4.
FIGURE 4.
Concentration dependence of the ZPI inhibition of fXa in the presence of PZ derivatives on PC/PS vesicles. The kobs values for the ZPI inhibition of fXa (0.5 nm) in the presence of PZ derivatives: pPZ (○), rPZ (•), and PZ-fX/LC chimera (□) (100 nm each) were determined on PC/PS vesicles (20 μm) in TBS/Ca2+ at room temperature by an amidolytic activity assay described under “Experimental Procedures.” The k2 values were calculated from the slopes of the straight lines and presented in Table 1. Data are derived from averages of at least 2–3 independent measurements.

References

    1. Ichinose, A., Takeya, H., Espling, E., Iwanaga, S., Kisiel, W., and Davie, E. W. (1990) Biochem. Biophys. Res. Commun. 172 1139–1144 - PubMed
    1. Sejima, H., Hayashi, T., Deyashiki, Y., Nishioka, J., and Suzuki, K. (1990) Biochem. Biophys. Res. Commun. 171 661–668 - PubMed
    1. Broze, G. J., Jr., and Miletich, J. P. (1984) J. Clin. Investig. 73 933–938 - PMC - PubMed
    1. Han, X., Fiehler, R., and Broze, G. J., Jr. (2000) Blood 96 3049–3055 - PubMed
    1. Han, X., Fiehler, R., and Broze, G. J., Jr. (1998) Proc. Natl. Acad. Sci. U. S. A. 95 9250–9255 - PMC - PubMed

Publication types

LinkOut - more resources